FDA conditionally approves drug for canine neuropathic painMay 13, 2026Liavium-CA1 is indicated for the management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs. The drug, with the active ingredient pregabalin, reduces the release of neurotransmitters that send pain signals in the spinal cord.
SPONSORED CONTENT1 dose, once a month.Defends dogs against ticks and fleas and also protects against heartworm disease, roundworms, hookworms and tapeworms. + Learn More
